Sphingolipid Metabolism and Signaling
Sphingolipid Metabolism and Signaling is a research topic within Molecular Biology. Science Explorer counts 15k research works in it since 1953. 9.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the role of sphingolipids, including sphingosine-1-phosphate and ceramide, in signaling and metabolism, with implications for health and disease such as lymphocyte egress, insulin resistance, cancer, and apoptosis.
- Sphingolipids
- Sphingosine-1-Phosphate
- Ceramide
- Lysophospholipids
- Sphingosine Kinase
- FTY720
- Lymphocyte Egress
- Insulin Resistance
- Cancer
- Apoptosis
- Research works
- 15k fractional, since 1953
- In the world top 10%
- 1.5k per year above
- Top-10% rate
- 9.9% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +1% the tick is no change
- Largest producer
China
39% of the 10 largest, 2022-now
Which countries lead Sphingolipid Metabolism and Signaling research?
By volume, China and the United States publish the most (798 and 525 works in 2022-now).
By volume, 2022-now
- 1
China 798 works
- 2
United States 525 works
- 3
Japan 167 works
- 4
Germany 133 works
- 5
Italy 87 works
- 6
India 86 works
- 7
South Korea 78 works
- 8
France 66 works
- 9
United Kingdom 61 works
- 10
Spain 56 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Sphingolipid Metabolism and Signaling research?
By volume in 2022-now, Shanghai Jiao Tong University publishes the most Sphingolipid Metabolism and Signaling research, followed by Harvard University and Virginia Commonwealth University.
By volume, 2022-now
- 1
Shanghai Jiao Tong University
China 21 works
- 2
Harvard University
United States 18 works
- 3
Virginia Commonwealth University
United States 16 works
- 4
Chinese Academy of Sciences
China 16 works
- 5
Capital Medical University
China 15 works
- 6
Centre National de la Recherche Scientifique
France 15 works
- 7
Sun Yat-sen University
China 15 works
- 8
Chinese Academy of Medical Sciences & Peking Union Medical College
China 14 works
- 9
Peking University
China 14 works
- 10
Sichuan University
China 14 works
Who are the leading researchers in Sphingolipid Metabolism and Signaling?
The most-cited researchers publishing on Sphingolipid Metabolism and Signaling include Shizuo Akira, Luigi Ferrucci and Frank B. Hu.
- 1
Shizuo Akira
Japan 342k citations
- 2
Luigi Ferrucci
United States 281k citations
- 3
Frank B. Hu
United States 281k citations
- 4
Hagop M. Kantarjian
United States 273k citations
- 5
Gordon Brent Mills
United States 265k citations
- 6
Charles M. Perou
United States 263k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Sphingolipid Metabolism and Signaling research done?
The largest centres of Sphingolipid Metabolism and Signaling research in 2022-now are Beijing (China), Shanghai (China), Guangzhou (China) and Tokyo (Japan).
Where is the best place to study Sphingolipid Metabolism and Signaling?
Among universities, judged by research, Shanghai Jiao Tong University, Harvard University and Nanjing University of Chinese Medicine score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Sphingolipid Metabolism and Signaling, country by countryIs Sphingolipid Metabolism and Signaling research growing?
Output in 2022-2025 was 1% higher than in 2018-2021, peaking in 2020. The fastest-growing topics are Sphingolipid Metabolism and Signaling.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Sphingolipid Metabolism and Signaling as a percentage of every work published that year, 0.0098% in 2024.
Fractional works of Sphingolipid Metabolism and Signaling over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Sphingolipid Metabolism and Signaling. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.